🌍 Worldwide🎗️ Cancer & Oncology📡 OpenAlex🕒 Updated November 2, 2026

Most-Cited Cancer Vaccines Papers This Year (2026)

As of November 2, 2026, “Dual-Targeting mRNA Cancer Vaccines for Simultaneous Antigen Presentation in Dendritic and Tumor Cells” leads Most-Cited Cancer Vaccines Papers This Year with 9 citations. “Engineering the future of precision cancer immunotherapy: Integrating neoantigen biology, engineered delivery platforms, and clinical translation.” is second and “Enhanced efficacy of a next-generation EEEV self-replicating RNA platform for combination cancer immunotherapies” third.

WhatsApp Telegram X Facebook ⓘ Methodology

🚫 No paid placement📡 Source: OpenAlex🕒 Updated November 2, 2026 ⓘ How we measure

🎗️2

Engineering the future of precision cancer immunotherapy: Integrating neoantigen biology, engineered delivery platforms, and clinical translation.Muhammad Masood Ur Rauf Hiraj Khan et al. · Materials Today Advances · 2026-05-073 citations

👑

🎗️1

Dual-Targeting mRNA Cancer Vaccines for Simultaneous Antigen Presentation in Dendritic and Tumor CellsYelee Kim et al. · ACS Nano · 2026-03-179 citations

🎗️3

Enhanced efficacy of a next-generation EEEV self-replicating RNA platform for combination cancer immunotherapiesShigeki Joseph Miyake-Stoner et al. · Molecular Therapy · 2026-03-253 citations

Full ranking

🎗️

Dual-Targeting mRNA Cancer Vaccines for Simultaneous Antigen Presentation in Dendritic and Tumor Cells ↗ •🏆 Leader

Yelee Kim et al. · ACS Nano · 2026-03-17

9 citationsCitations

🎗️

Engineering the future of precision cancer immunotherapy: Integrating neoantigen biology, engineered delivery platforms, and clinical translation. ↗ •

Muhammad Masood Ur Rauf Hiraj Khan et al. · Materials Today Advances · 2026-05-07

3 citationsCitations

🎗️

Enhanced efficacy of a next-generation EEEV self-replicating RNA platform for combination cancer immunotherapies ↗ •

Shigeki Joseph Miyake-Stoner et al. · Molecular Therapy · 2026-03-25

3 citationsCitations

🎗️

Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenic ↗ •

Claudia Tonini et al. · Journal for ImmunoTherapy of Cancer · 2026-05-01

2 citationsCitations

🎗️

Self-adjuvanting α-helical polypeptide simultaneously delivers neoantigen mRNAs and activates dendritic cells to eradicate tumors ↗ •

Joonsu Han et al. · Proceedings of the National Academy of Sciences · 2026-04-15

2 citationsCitations

🎗️

Peripheral vaccination-induced brain-resident memory CD8+ T cells durably protect mice against intracranial malignancy ↗ •

Madison R. Mix et al. · Journal of Clinical Investigation · 2026-04-14

2 citationsCitations

🎗️

Enhanced mRNA vaccine combined with immune checkpoint blockade efficiently suppresses tumor growth and metastasis ↗ •

Yufeng Zhang et al. · Journal of Nanobiotechnology · 2026-04-07

2 citationsCitations

🎗️

A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control ↗ •

Qi Liu et al. · Vaccines · 2026-03-05

2 citationsCitations

🎗️

Sequence-Anchored Shared Tumor-Specific Epitopes for Pre-Manufactured HLA-Matched mRNA Cancer Vaccine Libraries: A Pan-Cancer Framework ↗ •

Sarfaraz K. Niazi · Biomolecules · 2026-07-11

1 citationsCitations

🎗️

CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses ↗ •

Yibo Li et al. · Molecular Therapy Oncology · 2026-05-09

1 citationsCitations

How this ranking works

Ranked by citation count (OpenAlex) among research papers published this year whose title or abstract matches this topic. Citations build up over time, so the newest papers rank lower. For information only, not medical advice.

Methodology →

SourceOpenAlex

SignalCitations

Last updatedNov 2, 2026, 4:27 PM UTC

Top 10Citations of papers published this year